Cathi Ahearn

Cathi Ahearn currently serves as the Senior Vice President of Worldwide Commercial Portfolio Strategy at Bristol Myers Squibb, a position held since December 2021. Prior to this role, Ahearn spent over a decade at Roche, where significant accomplishments included serving as Vice President and Franchise Head for GI/GU Cancers and overseeing the TECENTRIQ program across multiple disease areas. Ahearn's earlier career includes various marketing and product management roles at Genentech and Schering-Plough Pharmaceuticals, starting as a Sales Representative and advancing to Director of Marketing for Avastin. Ahearn holds an MBA from Duke University's Fuqua School of Business and a BA in Psychology from UCLA.